Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Accumulated Depreciation (2018)

Neurogene's Accumulated Depreciation history spans 1 years, with the latest figure at $443000.0 for Q4 2018.

  • For Q4 2018, Accumulated Depreciation changed N/A year-over-year to $443000.0; the TTM value through Dec 2018 reached $443000.0, changed N/A, while the annual FY2018 figure was $443000.0, N/A changed from the prior year.
  • Accumulated Depreciation reached $443000.0 in Q4 2018 per NGNE's latest filing.
  • In the past five years, Accumulated Depreciation ranged from a high of $443000.0 in Q4 2018 to a low of $443000.0 in Q4 2018.